Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc.CTRV · Entity 8208 | Chief Medical Officer | July 06, 2017 | July 07, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hepion Pharmaceuticals, Inc.
Report date July 06, 2017 · Filed July 07, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,681 |
Reported balance
After 2017-07-06 transaction · row 1
1 source rowRow 1 · 2017-07-06 · Grant · Acquired 58,681 · Balance 58,681 F1: The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2017 Filed Jul 7, 2017 17:00 UTC | Hepion Pharmaceuticals, Inc. CTRV · Entity 8208 | GrantCommon Stock | 58,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-044099 · a4.xml · nonDerivative · entry 1 Sullivan-Bolyai John Z · CIK 0001668462 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,681 F1 · price: The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.